Data gathered: March 6
AI Stock Analysis - Ocean Biomedical (OCEA)
Analysis generated February 21, 2025. Powered by Chat GPT.
Ocean Biomedical is a company primarily engaged in the biomedical sector, with a focus on innovative solutions and medical research. The company has shown a dedication to pushing the boundaries of medical science and fostering advancements in healthcare. As of now, the company appears stable without recent spikes in hiring, indicative of a steady operational phase without significant expansions or cutbacks.
Stock Alerts - Ocean Biomedical (OCEA)
 |
Ocean Biomedical | March 5 Price is up by 6.1% in the last 24h. |
|
Ocean Biomedical | March 4 Price is down by -7.3% in the last 24h. |
|
Ocean Biomedical | March 3 Price is down by -6% in the last 24h. |
|
Ocean Biomedical | February 28 Price is down by -5.6% in the last 24h. |
Alternative Data for Ocean Biomedical
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 98 | Sign up | Sign up | Sign up |
| Webpage traffic | 2,000 | Sign up | Sign up | Sign up |
| Google Trends | 14 | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | N/A | Sign up | Sign up | Sign up |
| Facebook Followers | N/A | Sign up | Sign up | Sign up |
| Instagram Followers | 116 | Sign up | Sign up | Sign up |
| Reddit Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 48 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 4,598 | Sign up | Sign up | Sign up |
| Twitter Followers | 288 | Sign up | Sign up | Sign up |
| Twitter Mentions | 122 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 12 | Sign up | Sign up | Sign up |
About Ocean Biomedical
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer.
| Price | $0.09 |
| Target Price | Sign up |
| Volume | 13,070,000 |
| Market Cap | $26M |
| Year Range | $0.09 - $1.28 |
| Dividend Yield | 0% |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
 |
Ocean Biomedical announces findings in EGFR-mutant lung cancerFebruary 10 - Thefly.com |
|
Ocean Biomedical advances malaria vaccine research with new funding, pathwayJanuary 29 - Thefly.com |
Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development PathwayJanuary 29 - GlobeNewswire |
|
LAG-3 Immunotherapies Market Set for Rapid Growth in the Coming 10 Years Across the 7MM as Next-Generation Therapies Advance | DelveInsightFebruary 25 - GlobeNewswire |
|
Global Immune Checkpoint Inhibitors Market to Cross USD 100 Billion by 2032 | DelveInsightFebruary 18 - GlobeNewswire |
|
Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 110+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsightJanuary 28 - GlobeNewswire |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 0 | 770,000 | -1.2M | -5.5M | 0 | -0.201 |
| Q4 '23 | 0 | -640,000 | 140,000 | -17M | 0 | -0.487 |
| Q3 '23 | 0 | 2.4M | -2.9M | -14M | 0 | -0.530 |
| Q2 '23 | 0 | 2.7M | -4.2M | -13M | 0 | -0.390 |
| Q1 '23 | 0 | 12M | -27M | -67M | 0 | 0.430 |
Insider Transactions View All
| AJJARAPU SURENDRA K filed to buy 5,411,000 shares at $1. March 2 '23 |
Similar companies
Read more about Ocean Biomedical (OCEA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews & linkedin employees.
What is the Market Cap of Ocean Biomedical?
The Market Cap of Ocean Biomedical is $26M.
What is the current stock price of Ocean Biomedical?
Currently, the price of one share of Ocean Biomedical stock is $0.09.
How can I analyze the OCEA stock price chart for investment decisions?
The OCEA stock price chart above provides a comprehensive visual representation of Ocean Biomedical's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Ocean Biomedical shares. Our platform offers an up-to-date OCEA stock price chart, along with technical data analysis and alternative data insights.
Does OCEA offer dividends to its shareholders?
As of our latest update, Ocean Biomedical (OCEA) does not offer dividends to its shareholders. Investors interested in Ocean Biomedical should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Ocean Biomedical?
Some of the similar stocks of Ocean Biomedical are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.